Considering the link between neurodegeneration and oxidative stress due to the mitochondrial imbalance and the accumulation of reactive oxygen species (ROS), MAO-B was and still is, considered a valid therapeutic target for slowing down the progression of Parkinson’s disease. The gene discussed is MAOB; the disease is Parkinson disease.